AbbVie Already Dividend King? Why Apogee Deal Could Cement a Dynasty
AbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
Explore year-end ETF Tax-Loss Harvesting ideas to harvest losses before year-end, diversify replacements, and sharpen tax efficiency.
25,086 articlesAbbVie has quietly built a credible dividend track record since its 2013 spin-off from Abbott. The $10.9B Apogee deal...
NVIDIA’s latest results highlight a powerful software moat and growing AI infrastructure demand, underscoring why man...
AI chips run hot, and the race to cool them efficiently is reshaping data centers and stock stories. This article exp...
Fixed notes are more than a loan term. They can be a proactive hedge against vacancy gaps. Learn how investors using ...
A record blizzard shut down The Boston Globe's print operations for the first time in 153 years. Tuesday's edition wi...
The 30-year fixed rate slipped below 6% for the first time since 2022, sparking renewed hope for homebuyers and those...
A healthcare-focused dividend stock surged last year, outpacing the Nasdaq and delivering solid income. Analysts see ...
Compass Point flags three financials fresh ratings: wall on UWMC, RKT, and SLRC as rates ease and lending activity is...
SanDisk shares jumped about 6% on Friday as a persistent NAND shortage supports higher prices and prolonged demand fr...
Fastenal shows robust, tech-driven expansion while DNOW wrestles with ERP integration after a major acquisition, sett...
A small auto-enrollment default in 401(K) plans can cost the average saver hundreds of thousands over a lifetime, a n...
Women are breaking into top-paying, traditionally male-dominated fields. In 2026, surgeons, airline pilots, and softw...